Newton, MA, United States of America

David Proia

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Spotlight: David Proia

Introduction

David Proia, an accomplished inventor based in Newton, MA, has made significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, Proia’s work focuses primarily on advancing cancer treatment through innovative combination therapies.

Latest Patents

Among his latest patents, Proia has developed a pharmaceutical composition that combines HSP90 inhibitors and PD-1 inhibitors for treating cancer. This formulation includes specific chemical compounds such as 3-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(1-methyl-indol-5-yl)-5-hydroxy-[1,2,4] triazole or related derivatives. Included in his innovations is also a method aimed at utilizing these compositions to treat subjects with cancer effectively.

Another notable patent involves combination therapies that consist of pharmacological compounds. This invention provides a unique approach by linking an effector moiety to a binding moiety that targets specific biological entities. The SDC-TRAP compounds exemplify this invention, where a protein interacting binding moiety is conjugated with a cytotoxic agent to enhance cancer treatment protocols.

Career Highlights

David Proia has held significant positions in companies that specialize in pharmaceutical innovations. He has contributed his expertise to Synta Pharmaceuticals Corporation and Madrigal Pharmaceuticals, Inc., where he developed cutting-edge therapies aimed at improving patient outcomes in oncology.

Collaborations

Throughout his career, Proia has collaborated with notable colleagues such as Iman El-Hariry and Vojo Vukovic. These partnerships have played a crucial role in shaping the innovative landscape of cancer therapeutics and furthering research in the pharmaceutical field.

Conclusion

David Proia stands out as a notable figure in pharmaceutical innovation, particularly in the realm of cancer treatment. With a robust portfolio of patents and a history of collaboration with industry pioneers, Proia continues to elevate the standards of therapeutic development, driving forward the mission to find effective cancer treatments. His work not only showcases his ingenuity but also his commitment to advancing medical science for improved patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…